Los puntos clave no están disponibles para este artículo en este momento.
Idiopathic FSGS recurs post-transplant in one third of cases and is associated with a five-fold higher risk of graft loss. Response to treatment is associated with significantly better outcomes but is achieved in only half of the cases.
Uffing et al. (Thu,) studied this question.